Cargando…
An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform
The development of blood-based biomarkers of Alzheimer’s disease (AD) pathology as tools for screening the general population, and as the first step in a multistep process to determine which non-demented individuals are at greatest risk of developing AD dementia, is essential. Proteins that are refl...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908531/ https://www.ncbi.nlm.nih.gov/pubmed/31833025 http://dx.doi.org/10.1007/s40120-019-00164-5 |